Lung Cancer Epidemiologic Changes: Implications in Diagnosis and Therapy

2017 ◽  
pp. 323-332 ◽  
Author(s):  
Philip Ong ◽  
David Ost
Keyword(s):  
Lung Cancer ◽  
Diagnosis And Therapy

scholarly journals Emerging applications of nanoparticles for lung cancer diagnosis and therapy

2013 ◽  
Vol 3 (1) ◽  
Author(s):  
Uday Kumar Sukumar ◽  
Bharat Bhushan ◽  
Poornima Dubey ◽  
Ishita Matai ◽  
Abhay Sachdev ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Diagnosis ◽  
Diagnosis And Therapy ◽  
Lung Cancer Diagnosis ◽  
Cancer Diagnosis And Therapy

Emerging roles of microRNAs as a regulator in the progression of lung cancer and their implications in its diagnosis and therapy

2019 ◽  
pp. 293-318
Author(s):  
Surya Kant Tripathi ◽  
Kamal Pandey ◽  
Munmun Panda ◽  
Bijesh K. Biswal
Keyword(s):  
Lung Cancer ◽  
Diagnosis And Therapy

scholarly journals A review of penile metastasis

2012 ◽  
Vol 6 (1) ◽  
pp. 10 ◽  
Author(s):  
Luigi Mearini ◽  
Renato Colella ◽  
Alessandro Zucchi ◽  
Elisabetta Nunzi ◽  
Carlo Porrozzi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Penile Cancer ◽  
Developed Countries ◽  
Secondary Cancer ◽  
Primary Tumors ◽  
Penile Metastasis ◽  
Diagnosis And Therapy ◽  
Primary Disease ◽  
Rare Site

Penile cancer as primary disease is relatively rare in developed countries. The penis is a rare site of metastases in spite of its rich vascularization. Approximately 500 cases have been reported in the literature; almost 70% of primary lesions are of pelvic origin (from genitourinary or recto-sigmoid primary tumors). We describe a case of penile metastasis from lung cancer. The rarity of the event prompted us to also explore related reviews and discuss the incidence, physiopathology, diagnosis and therapy of penile secondary cancer.

Specific expression of OATPs in primary small cell lung cancer (SCLC) cells as novel biomarkers for diagnosis and therapy

2015 ◽  
Vol 356 (2) ◽  
pp. 517-524 ◽  
Author(s):  
Stefan Brenner ◽  
Lukas Klameth ◽  
Juliane Riha ◽  
Madeleine Schölm ◽  
Gerhard Hamilton ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Specific Expression ◽  
Diagnosis And Therapy ◽  
Novel Biomarkers

International Conference on ‘Non Small Cell Lung Cancer: Standards and New Trends in Diagnosis and Therapy’, October 5–7, 2001, Medical Academy of Bialystok, Bialystok, Poland

Lung Cancer ◽  
2002 ◽  
Vol 37 (1) ◽  
pp. 109-112
Author(s):  
J. Niklinski ◽  
J. Laudanski ◽  
L. Chyczewski ◽  
J. Jassem ◽  
J.R. Fischer ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
International Conference ◽  
Diagnosis And Therapy ◽  
Medical Academy

Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy

2016 ◽  
Vol 33 (2) ◽  
Author(s):  
Biagio Ricciuti ◽  
Clelia Mencaroni ◽  
Luca Paglialunga ◽  
Francesco Paciullo ◽  
Lucio Crinò ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Cancer Biology ◽  
Noncoding Rnas ◽  
Small Cell ◽  
Long Noncoding Rnas ◽  
Small Cell Lung ◽  
Diagnosis And Therapy

A Soft Robot for Peripheral Lung Cancer Diagnosis and Therapy

Soft Robotics ◽  
2021 ◽  
Author(s):  
Max McCandless ◽  
Alexander Perry ◽  
Nicholas DiFilippo ◽  
Ashlyn Carroll ◽  
Ehab Billatos ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Diagnosis ◽  
Soft Robot ◽  
Peripheral Lung Cancer ◽  
Diagnosis And Therapy ◽  
Lung Cancer Diagnosis ◽  
Peripheral Lung ◽  
Cancer Diagnosis And Therapy

scholarly journals Non-Coding RNAs in Cancer Diagnosis and Therapy: Focus on Lung Cancer

Cancers ◽  
2021 ◽  
Vol 13 (6) ◽  
pp. 1372
Author(s):  
Patricia Le ◽  
Giulia Romano ◽  
Patrick Nana-Sinkam ◽  
Mario Acunzo
Keyword(s):  
Lung Cancer ◽  
Therapeutic Potential ◽  
Biological Fluids ◽  
Metastatic Potential ◽  
Specific Expression ◽  
Lung Cancers ◽  
Diagnosis And Therapy ◽  
Oncogenic Pathways ◽  
Non Coding Rnas ◽  
Apoptotic Pathways

Over the last several decades, clinical evaluation and treatment of lung cancers have largely improved with the classification of genetic drivers of the disease, such as EGFR, ALK, and ROS1. There are numerous regulatory factors that exert cellular control over key oncogenic pathways involved in lung cancers. In particular, non-coding RNAs (ncRNAs) have a diversity of regulatory roles in lung cancers such that they have been shown to be involved in inducing proliferation, suppressing apoptotic pathways, increasing metastatic potential of cancer cells, and acquiring drug resistance. The dysregulation of various ncRNAs in human cancers has prompted preclinical studies examining the therapeutic potential of restoring and/or inhibiting these ncRNAs. Furthermore, ncRNAs demonstrate tissue-specific expression in addition to high stability within biological fluids. This makes them excellent candidates as cancer biomarkers. This review aims to discuss the relevance of ncRNAs in cancer pathology, diagnosis, and therapy, with a focus on lung cancer.

Sign in / Sign up

Export Citation Format

Share Document